PTX 0.00% 5.2¢ prescient therapeutics limited

updated chart, page-6

  1. 1,571 Posts.
    lightbulb Created with Sketch. 378
    There could be a surprise update on the trials or something around Car-t. But the PTX100 trial is expected to complete mid year and PTX200 end of year. So no news expected atm.

    Imo, the recent price action is a continuation of a trend since the last capital raise and the announcement of our acquisition of the Omnicar platform. The recent announcement of our Car-t strategy around Omnicar put flesh on the bones and the market likes what it sees. Chimera listing and the growing hype around Car-t added to the momentum.

    Omni car has transformed Prescient into a different company with a high quality cutting edge agenda in a hot space and still with a low mkt cap.
    Investors could wait for a big pullback but the share price will rise in anticipation of PTX100/200 as we approach mid year and the end of the year, so that window is short.
    Next year should see a growing buzz around Car-t with Prescients maturing platform going to work for the company with more positive company transforming announcements. So short of a market correction the share price should remain supported and a climb to above 20c is to be expected over the next three to six months. AIMO
    All aboard... toot toot!
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
5.2¢
Change
0.000(0.00%)
Mkt cap ! $41.87M
Open High Low Value Volume
5.4¢ 5.4¢ 5.0¢ $44.20K 858.6K

Buyers (Bids)

No. Vol. Price($)
5 97252 5.0¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 97976 2
View Market Depth
Last trade - 16.10pm 30/04/2024 (20 minute delay) ?
Last
5.0¢
  Change
0.000 ( 3.85 %)
Open High Low Volume
5.3¢ 5.3¢ 5.0¢ 119475
Last updated 15.32pm 30/04/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.